# Ainimo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ainimo

- Industry: Biotechnology
- Headquarters: Jiaxing, China
- Latest round: Series A (Apr 26, 2023)
- Investors on record: 2

## About

Based in Jiaxing, China and founded in 2022, Ainimo operates as a manufacturer of experimental large animals and innovative animal disease models, focusing on the production of experimental large animals and the development of innovative animal disease models. The company has obtained a laboratory animal production license and a laboratory animal use license. Ainimo has established a laboratory animal production base in the eastern suburbs of Nanjing. In April 2023, Ainimo completed a series A funding from new investor Goldport Capital and returning investor RegenGeek.

The company is committed to pioneering innovative animal disease models and has nearly 700 Beagle breeders and has completed the development and application of over 20 animal models. Ainimo's animal disease models cover a wide range of areas including cardiovascular, central nervous system, oncology, metabolic, ophthalmic, autoimmune and liver and kidney diseases.

## Funding rounds

- Series A, Apr 26, 2023 — Goldport Capital, RegenGeek

## Investors

- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Series A
- RegenGeek — Series A